The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans

John E. Paderi, Kate Stuart, Michael Sturek, Kinam Park, Alyssa Panitch

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Collagen is a potent stimulator for platelet adhesion, activation, and thrombus formation, and provides a means for controlling blood loss due to injury, and recruiting inflammatory cells for fighting infection. Platelet activation is not desirable however, during balloon angioplasty/stent procedures in which balloon expansion inside an artery exposes collagen, initiating thrombosis, and inflammation. We have developed biomimetic polymers, termed peptidoglycans, composed of a dermatan sulfate backbone with covalently attached collagen-binding peptides. The peptidoglycan binds to collagen, effectively masking it from platelet activation. The lead peptidoglycan binds to collagen with high affinity (KD = 24 nm) and inhibits platelet binding and activation on collagen in both static studies and under flow, while promoting endothelial regrowth on collagen. Application for angioplasty is demonstrated in the Ossabaw miniature pig by fast delivery to the vessel wall through a therapeutic infusion catheter with a proprietary PTFE porous balloon. The peptidoglycan is an approach for locally preventing platelet deposition and activation on collagen. It can be used during angioplasty to prevent platelet deposition on target vessels and could be used in any vessel, including those not amenable to stent deployment.

Original languageEnglish (US)
Pages (from-to)2516-2523
Number of pages8
JournalBiomaterials
Volume32
Issue number10
DOIs
StatePublished - Apr 1 2011

Fingerprint

Balloon Angioplasty
Peptidoglycan
Balloons
Platelet Activation
Platelets
Collagen
Adhesion
Chemical activation
Stents
Angioplasty
Thrombosis
Dermatan Sulfate
Biomimetics
Catheters
Polytetrafluoroethylene
Polytetrafluoroethylenes
Peptides
Polymers
Blood
Swine

Keywords

  • Balloon Angioplasty
  • Biomimetic material
  • Collagen
  • Intimal hyperplasia
  • Peptide
  • Platelet
  • Thrombosis

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. / Paderi, John E.; Stuart, Kate; Sturek, Michael; Park, Kinam; Panitch, Alyssa.

In: Biomaterials, Vol. 32, No. 10, 01.04.2011, p. 2516-2523.

Research output: Contribution to journalArticle

Paderi, John E. ; Stuart, Kate ; Sturek, Michael ; Park, Kinam ; Panitch, Alyssa. / The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. In: Biomaterials. 2011 ; Vol. 32, No. 10. pp. 2516-2523.
@article{5c1788100ca440e994dc7d672ff6d585,
title = "The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans",
abstract = "Collagen is a potent stimulator for platelet adhesion, activation, and thrombus formation, and provides a means for controlling blood loss due to injury, and recruiting inflammatory cells for fighting infection. Platelet activation is not desirable however, during balloon angioplasty/stent procedures in which balloon expansion inside an artery exposes collagen, initiating thrombosis, and inflammation. We have developed biomimetic polymers, termed peptidoglycans, composed of a dermatan sulfate backbone with covalently attached collagen-binding peptides. The peptidoglycan binds to collagen, effectively masking it from platelet activation. The lead peptidoglycan binds to collagen with high affinity (KD = 24 nm) and inhibits platelet binding and activation on collagen in both static studies and under flow, while promoting endothelial regrowth on collagen. Application for angioplasty is demonstrated in the Ossabaw miniature pig by fast delivery to the vessel wall through a therapeutic infusion catheter with a proprietary PTFE porous balloon. The peptidoglycan is an approach for locally preventing platelet deposition and activation on collagen. It can be used during angioplasty to prevent platelet deposition on target vessels and could be used in any vessel, including those not amenable to stent deployment.",
keywords = "Balloon Angioplasty, Biomimetic material, Collagen, Intimal hyperplasia, Peptide, Platelet, Thrombosis",
author = "Paderi, {John E.} and Kate Stuart and Michael Sturek and Kinam Park and Alyssa Panitch",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.biomaterials.2010.12.025",
language = "English (US)",
volume = "32",
pages = "2516--2523",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans

AU - Paderi, John E.

AU - Stuart, Kate

AU - Sturek, Michael

AU - Park, Kinam

AU - Panitch, Alyssa

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Collagen is a potent stimulator for platelet adhesion, activation, and thrombus formation, and provides a means for controlling blood loss due to injury, and recruiting inflammatory cells for fighting infection. Platelet activation is not desirable however, during balloon angioplasty/stent procedures in which balloon expansion inside an artery exposes collagen, initiating thrombosis, and inflammation. We have developed biomimetic polymers, termed peptidoglycans, composed of a dermatan sulfate backbone with covalently attached collagen-binding peptides. The peptidoglycan binds to collagen, effectively masking it from platelet activation. The lead peptidoglycan binds to collagen with high affinity (KD = 24 nm) and inhibits platelet binding and activation on collagen in both static studies and under flow, while promoting endothelial regrowth on collagen. Application for angioplasty is demonstrated in the Ossabaw miniature pig by fast delivery to the vessel wall through a therapeutic infusion catheter with a proprietary PTFE porous balloon. The peptidoglycan is an approach for locally preventing platelet deposition and activation on collagen. It can be used during angioplasty to prevent platelet deposition on target vessels and could be used in any vessel, including those not amenable to stent deployment.

AB - Collagen is a potent stimulator for platelet adhesion, activation, and thrombus formation, and provides a means for controlling blood loss due to injury, and recruiting inflammatory cells for fighting infection. Platelet activation is not desirable however, during balloon angioplasty/stent procedures in which balloon expansion inside an artery exposes collagen, initiating thrombosis, and inflammation. We have developed biomimetic polymers, termed peptidoglycans, composed of a dermatan sulfate backbone with covalently attached collagen-binding peptides. The peptidoglycan binds to collagen, effectively masking it from platelet activation. The lead peptidoglycan binds to collagen with high affinity (KD = 24 nm) and inhibits platelet binding and activation on collagen in both static studies and under flow, while promoting endothelial regrowth on collagen. Application for angioplasty is demonstrated in the Ossabaw miniature pig by fast delivery to the vessel wall through a therapeutic infusion catheter with a proprietary PTFE porous balloon. The peptidoglycan is an approach for locally preventing platelet deposition and activation on collagen. It can be used during angioplasty to prevent platelet deposition on target vessels and could be used in any vessel, including those not amenable to stent deployment.

KW - Balloon Angioplasty

KW - Biomimetic material

KW - Collagen

KW - Intimal hyperplasia

KW - Peptide

KW - Platelet

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=79251593784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251593784&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.12.025

DO - 10.1016/j.biomaterials.2010.12.025

M3 - Article

C2 - 21216002

AN - SCOPUS:79251593784

VL - 32

SP - 2516

EP - 2523

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 10

ER -